http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05000365-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1ea5482c57a7b21ad12fa369c77773d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-32 |
| filingDate | 2003-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc9462840c0544bb3ae24667d9fbc8ac |
| publicationDate | 2005-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-PA05000365-A |
| titleOfInvention | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND METHODS OF USE OF THE SAME. |
| abstract | A pharmaceutical composition comprising a pharmaceutical diluent and a compound of formula IV is described wherein: R21 = H, alkyl of 1 to 20 carbon atoms, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, -CH2OR25, -C ( O) R25, -CO (O) R25, -C (O) NR25R26, -CH2C (O) R25, or -CH2C (O) NHR25, where R25 and R26 are each independently hydrogen, alkyl of 1 to 10 atoms of carbon, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, which optionally contain one or more halogen atoms. R22 = -OH, -0R27, -OCH2C (O) R27, -OCH2C (O) NHR27, -OC (O) R27, -OC (O) 0R27, -OC (O) NHNH-R5, or -OC (O ) NR27R28, where R27 and R28 are each independently hydrogen, alkyl of 1 to 20 carbon atoms, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, and where R27 and R28 may each optionally contain halogen atoms; R23 and R24, the same or different from each other, are alkyl of 1 to 20 carbon atoms, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl. Methods of using such formulations for the treatment of cancer, to effect weight loss, to treat infections based on microbes, to inhibit neuropeptide Y and / or fatty acid synthase, and to stimulate CPT- are also described. l. |
| priorityDate | 2002-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 309.